
Last 4 earnings calls · through Q2 FY2026
The bull case is that core growth is accelerating as volume returns, so the second half depends on industrial water demand and consumables rather than on further price rises.
A large share of sales is consumables and software attached to installed equipment, which steadies revenue when equipment orders are postponed and gives price increases room to hold.
Management keeps buying small water and software businesses that add growth and come with cost and channel synergies, funded from cash rather than new borrowing.
The bear case is that the fastest-growing verticals, data centres and their supplier industries, remain too small to move total sales, so growth rests on mature municipal and CPG markets.
Equipment purchases in packaging and colour testing are discretionary, so weak industrial demand can pull the growth rate down even while recurring consumable revenue holds steady.
Chemical and component costs remain volatile, and management relies on repeated customer-by-customer price talks to protect dollar margins rather than to expand them.
In short: Core growth is accelerating on volume, while deferrable equipment orders and China water remain risks.
At the start of the year management called low-single-digit core growth a prudent assumption; it now guides to roughly 5% to 6% in the second half, led by volume rather than price.
Recurring revenue reached $915 million, 62% of segment revenue and up 12.1% year on year, because consumables and software follow every instrument and printer placed with a customer.
About $1 billion went into In-Situ, GlobalVision and Alfaa UV this year, and management expects these additions to lift total sales growth above the core rate in 2026.
Data centre sales were described as a very big opportunity two quarters ago; management now says they will not meaningfully add to core growth this year because the base is still small.
Sales in packaging and colour dropped as automotive, textile and building-material customers postponed one-time colour testing and inspection equipment purchases, which management calls nonrecurring.
In short: Cash generation is strong and debt is low, while margin gains depend on a cost program paying out later.
Free cash flow of $1.0 billion equals 18.4% of revenue, and the business needs little capital spending, so cash is available for acquisitions and buybacks without adding debt.
The new cost program is excluded from 2026 guidance, with roughly half the savings expected in 2027 and the full amount in 2028, layered on top of the usual fall-through on added sales.
Operating margin slipped 1.5 points to 21.4% as acquisition dilution and duplicate production lines at PQI offset better gross margin, and the quarter also benefited from one-off tariff refunds.
Diluted shares rose 1.6% between 2022 and 2025, so the repurchase program first offsets stock-based compensation before it adds anything to per-share earnings.
In short: Installed equipment keeps customers tied in, while China municipal funding and chemical costs test pricing.
About 75% of sales go direct and much of the revenue is consumables needed to keep plants running, so customers rarely switch suppliers to save money.
Management expects price to land at or above the high end of its 100 to 200 basis point range in 2026, with consumables taking more price than equipment.
Water Quality sales in China slipped because government money has not reached municipal utilities, so the segment depends on industrial wins and on PQI comparisons that are getting easier.
ChemTreat passes through part of its raw material cost swings in customer pricing, which limits how much margin improvement water treatment can deliver when chemical costs are volatile.